Next Post

UNITY Biotechnology Announces Appointment of Accomplished Finance and Operations Executive Michael Samar to the Board of Directors

[ad_1] Unity Biotechnology, Inc. SAN FRANCISCO, May well 26, 2022 (World NEWSWIRE) — UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology enterprise acquiring therapeutics to gradual, halt, or reverse diseases of growing old, now declared that Michael Samar, current chief financial officer at Assembly Bio, has been appointed to the […]